Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Drug for treating systemic scleroderma

A systemic sclerosis and drug technology, applied in the field of medicine, can solve problems such as side effects, poor curative effect, and drugs that cannot meet the needs of patients, and achieve quick results

Inactive Publication Date: 2019-04-30
史良侃
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are also many drugs for the treatment of systemic scleroderma, but most of them are not very effective, and many drugs will produce certain side effects
With the development of society, these drugs can no longer meet the needs of patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0010] The present invention will be further described in detail in conjunction with specific embodiments below.

[0011] A medicament for the treatment of systemic scleroderma, consisting of:

[0012] 10g-20g of black medicine, 10g-20g of cinnamon, 10g-20g of iron clad gold, 10g-20g of five fingers, 10g-20g of creek yellow grass, 10g-20g of small flying grass, 10g-20g of cactus, 10g-20g of duck foot veneer, Astragalus 10g-20g and Cistanche 10g-20g.

[0013] As a preference, the medicine can be made into decoction.

[0014] Preferably, the drug can be made into tablets.

[0015] Preferably, the drug can be made into capsules.

[0016] The beneficial effect of the present invention is that it can effectively treat systemic scleroderma, has quick effect, has no side effect and is suitable for people of all ages and genders.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a drug for treating systemic scleroderma, which comprises the following components: 10g-20g of lindera aggregata, 10g-20g of cinnamon, 10g-20g of berchemia lineata, 10g-20g ofRadix Fici Hirtae, 10g-20g of linearstripe rabdosia herb, 10g-20g of thymifoious euphorbia herb, 10g-20g of cactus, 10g-20g of taxillus chinensis danser, 10g-20g of Radix Astragali, and 10g-20g of cistanche. The drug for treating systemic scleroderma has the beneficial effects of being effective for treating systemic scleroderma, has quick effect and no side effect, and is suitable for people of different ages and genders.

Description

technical field [0001] The invention belongs to the field of medicines, in particular to a medicine for treating systemic scleroderma. Background technique [0002] Systemic scleroderma is a common, multiple-occurring condition that occurs in all age groups, men, women, and children. At present, there are also many drugs for the treatment of systemic scleroderma, but most of them are not very effective, and many drugs will produce certain side effects. With the development of society, these drugs can no longer meet the needs of patients. Contents of the invention [0003] The technical problem to be solved by the present invention is to provide a drug for treating systemic scleroderma, which can treat systemic scleroderma conveniently and has no side effects. [0004] The technical scheme adopted in the present invention is: a kind of medicine for treating systemic scleroderma, is made up of following composition: [0005] 10g-20g of black medicine, 10g-20g of cinnamon,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/72A61K9/00A61K9/20A61K9/48A61P17/00
CPCA61K36/72A61K9/0095A61K9/20A61K9/48A61K36/25A61K36/33A61K36/47A61K36/481A61K36/53A61K36/54A61K36/60A61K36/64A61K2300/00
Inventor 史良侃
Owner 史良侃
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products